Results 71 to 80 of about 15,828 (290)

Anoikis in cell fate, physiopathology, and therapeutic interventions

MedComm, Volume 5, Issue 10, October 2024.
1. Anoikis is an integrin‐dependent form of apoptosis and can affect cell fate. 2. Anoikis widely exists in the physiological and pathological processes of life. 3. Anoikis‐based regulatory strategies are potential targets for therapeutic intervention.
Jie Mei, Xue‐Yao Jiang, Hui‐Xiang Tian, Ding‐Chao Rong, Jia‐Nan Song, Luozixian Wang, Yuan‐Shen Chen, Raymond C. B. Wong, Cheng‐Xian Guo, Lian‐Sheng Wang, Lei‐Yun Wang, Peng‐Yuan Wang, Ji‐Ye Yin   +12 more
wiley   +1 more source

Novel patient-centered approach to facilitate same-day discharge in patients undergoing elective percutaneous coronary intervention [PDF]

, 2018
Background Same‐day discharge ( SDD ) after elective percutaneous coronary intervention is safe, less costly, and preferred by patients, but it is usually performed in low‐risk patients,
Amin, Amit P, Bach, Richard G, Caruso, Mary, Crimmins-Reda, Patricia, Dennis, Brandy, Kulkarni, Hemant, Kurz, Howard I, Lasala, John M, Miller, Samantha, Pendegraft, Marissa, Pierce, Andrew, Rahn, Brandon, Singh, Jasvindar, Sorensen, Katrine, Zajarias, Alan   +14 more
core   +2 more sources

Mechanism of Bile Acid in Regulating Platelet Function and Thrombotic Diseases

Advanced Science, Volume 11, Issue 32, August 27, 2024.
Bile acids play critical roles in platelet activation via Syk, PLCγ2, PI3K, Akt, and ERK1/2 pathway, which is also associated with Syntaxin‐11 and NCK1. Additional Bile acids (LCA) supplementation attenuated atherosclerotic plaque development and reduce the inflammation in mice.
Xianghui Zhou, Xin Zhou, Zhao Zhang, Ruirui Zhu, Meng Lu, Keyu Lv, Chao Fang, Zhangyin Ming, Zhipeng Cheng, Yu Hu   +9 more
wiley   +1 more source

Glycoprotein IIb/IIIa inhibitors for cardiogenic shock complicating acute myocardial infarction: a systematic review, meta-analysis, and meta-regression

Journal of Intensive Care, 2020
Background Cardiogenic shock complicates 5–10% of myocardial infarction (MI) cases. Data about the benefit of glycoprotein IIb/IIIa inhibitors (GPI) in these patients is sparse and conflicting. Methods We performed a systematic review, meta-analysis, and
Carolina Saleiro, Rogério Teixeira, Diana De Campos, João Lopes, Bárbara Oliveiros, Marco Costa, Lino Gonçalves   +6 more
doaj   +1 more source

Intra-Arterial Infusion of a Glycoprotein IIb/IIIa Antagonist for the Treatment of Thromboembolism During Coil Embolization of Intracranial Aneurysm: A Comparison of Abciximab and Tirofiban

American Journal of Neuroradiology, 2013
BACKGROUND AND PURPOSE: Abciximab and tirofiban are commonly used for the treatment of thromboembolisms that form during coiling of intracranial aneurysms; however, it is not known which of these inhibitors is safer and more effective.
H.W. Jeong, S.-C. Jin
semanticscholar   +1 more source

Platelet glycoprotein IIb/IIIa antagonists in ischemic stroke patients without endovascular therapy: A meta‐analysis

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, Volume 44, Issue 8, Page 675-691, August 2024.
Abstract Platelet glycoprotein (GP) IIb/IIIa antagonists have been employed in selective patients after endovascular therapy (EVT) for acute ischemic stroke (AIS), yet application in patients without EVT is debated. This meta‐analysis of randomized controlled studies on AIS patients without EVT assessed the effectiveness and safety of platelet GP IIb ...
Dongjun Xu, Cheng Yang, Wei Cao, Xinyu Zhang, Shucong Yang, Xuning Shen, Jun Xu, Huijie Yu   +7 more
wiley   +1 more source

Safety and efficacy of abciximab as an adjunct to percutaneous coronary intervention

Vascular Health and Risk Management, 2010
Jennifer Vergara-Jimenez, Pierluigi TricociDepartment of Medicine-Cardiology, Duke Clinical Research Institute, Durham, North Carolina, USAAbstract: Abciximab is a widely studied glycoprotein IIb/IIIa inhibitor, specifically in the setting of patients ...
Jennifer Vergara-Jimenez, Pierluigi Tricoci   +1 more
doaj  

Abciximab for thrombolysis during intracranial aneurysm coiling [PDF]

, 2018
Introduction: Thrombotic events are a common and severe complication of endovascular aneurysm treatment with significant impact on patients' outcome.
Byrne, James, Corkill, Rufus, Gralla, Jan, Kuker, Wilhem, Lalloo, Shivendra, Molyneux, Andrew, Rennie, Adam   +6 more
core  

Rescue angioplasty in acute myocardial infarction [PDF]

, 2007
BACKGROUND: Acute myocardial infarction is a serious and frequent illness, and its treatment with thrombolytic therapy or percutaneous coronary intervention (PCI) is well established. Rescue PCI is an alternative when thrombolysis fails.
Carvalho, Antonio Carlos, Moraes, Eraldo Ribeiro Ferreira Leão de   +1 more
core   +1 more source

Abciximab and heparin versus bivalirudin for non-ST-elevation myocardial infarction.

New England Journal of Medicine, 2011
BACKGROUND The combination of glycoprotein IIb/IIIa inhibitors and heparin has not been compared with bivalirudin in studies specifically involving patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention
A. Kastrati, F. Neumann, S. Schulz, S. Massberg, R. Byrne, Miroslaw Ferenc, K. Laugwitz, J. Pache, I. Ott, J. Hausleiter, M. Seyfarth, M. Gick, D. Antoniucci, A. Schömig, P. Berger, J. Mehilli   +15 more
semanticscholar   +1 more source